Rare Disease Day? is February 28th this year and was created to raise awareness to bring about change. Since so few are affected by a given rare disease, there often is not enough attention, research, or funding for most rare diseases.? There are several peptides either commercially approved or in clinical trials for treating rare diseases.? Our blog covers peptides for the treatment of rare diseases: https://lnkd.in/eM7aZFH9 #cgmp #peptides #cdmo #api #drugdevelopment #peptidetherapeutics #rarediseases #rarediseaseday
AmbioPharm - A Global Peptide CDMO
制药业
North Augusta，SC 6,415 位关注者
Global Peptide Contract Development & Manufacturing Organization (CDMO).
关于我们
AmbioPharm, a global peptide CDMO, was founded in 2005 and is headquartered in North Augusta, South Carolina, USA specializing in developing highly efficient manufacturing processes for peptide-based Active Pharmaceutical Ingredients (APIs) at small to very large scales. In our manufacturing facilities in South Carolina, USA and Shanghai, China, we manufacture New Chemical Entities (NCEs) under cGMP for clients worldwide. Both facilities have been inspected multiple times by the FDA with excellent outcomes.
- 网站
-
https://www.ambiopharm.com
AmbioPharm - A Global Peptide CDMO的外部链接
- 所属行业
- 制药业
- 规模
- 501-1,000 人
- 总部
- North Augusta，SC
- 类型
- 私人持股
- 创立
- 2005
- 领域
- NCEs、Cosmetic Peptides、GMP Peptides、Peptides、Custom Peptide Synthesis、Peptide Active Pharmaceutical Ingredients (APIs)、NCE peptides、Preclinical Manufacturing、Process Development、Analytical Methods Support、Regulatory Support、Commercial Peptide Manufacturing、GMP Peptide Manufacturing、 Peptide Contract Development & Manufacturing Organization (CDMO)、Clinical Peptides、Agricultural peptides、Peptide API Manufacturing、Clinical Grade Peptide Manufacturing、Peptide Manufacturing和FDA Inspected
地点
AmbioPharm - A Global Peptide CDMO员工
动态
-
Let's meet at TIDES Asia! We would love to learn about your projects and discuss how AmbioPharm can help with the manufacturing and development of your clinical peptide. ? Or meet with us at an upcoming Conference: TIDES Asia | Feb 26-28 | Kyoto, Japan NextGen Biomed (Biologics UK) | March 12-14 |Booth 28 | London, UK DCAT Week | March 17-20 | NYC, NY USA ?#TIDESAsia #GMP #peptides
-
-
??Did you know that there are different manufacturing approaches that can be taken for toxicology/Phase I batches as you advance your peptide through the phases of clinical development? Learn more in our brief FAQ here: FAQ: What synthesis approach should be taken for a toxicology (tox) and Phase I batch? https://lnkd.in/eZMDen2Y #peptide #peptides #clinicaldevelopment #researchanddevelopment #cgmp #toxicology
-
We're #hiring a new Quality Assurance Engineer in North Augusta, South Carolina. Apply today or share this post with your network.
-
With a wide range of experience in a several peptide synthesis strategies (LPPS, SPPS, hybrid, convergent, microwave, and beyond), AmbioPharm peptide scientists have a wealth of experience. We evaluate each peptide sequence to determine which strategy is best. Our expertise in peptide synthesis covers simple to complex sequences, while maintaining stringent quality control. Whether your project is a straightforward linear peptide, or a complex peptide macrocycle, or anything in between, we have the experience and equipment to meet your project needs and we can cover a wide range, from early phase clinical projects to large commercial scales. To learn more about the peptide synthesis strategies we use, please visit: https://lnkd.in/gPwGtPvg?? ? #cgmp #peptides #cdmo #innovation #api #drugdevelopment #peptidesynthesis #peptidetherapeutics #SPPS #LPPS #qualitycontrol
-
-
We are looking forward to returning to DCAT (Drug, Chemical & Associated Technologies Association) this coming March. If you are planning on attending this event, please reach out to schedule a meeting, we would love to discuss how we can meet your peptide API manufacturing and development needs! https://lnkd.in/dVbA_hKe Upcoming 2025 Events: TIDES Asia | Feb 26-28 | Kyoto, Japan NextGen Biomed (Biologics UK) | March 12-14 |Booth 28 | London, UK DCAT Week | March 17-20 | NYC, NY USA #dcatweek
-
-
February 4th marks World Cancer Day. A devastating disease, it is hard to find anyone whose life has not been touched by cancer and our hearts go out to those who have been impacted. Our updated blog highlights the many ways peptides are used in cancer treatment and prevention. https://lnkd.in/egtv3RhS #cancer #peptides #api #drugdevelopment #peptidetherapeutics?#WorldCancerDay
-
-
AmbioPharm - A Global Peptide CDMO转发了
Happy to welcome AmbioPharm - A Global Peptide CDMO as a Silver Sponsor of #NextGenBiomed2025! ?? A global leader in peptide-based Active Pharmaceutical Ingredients (APIs), AmbioPharm specialises in developing efficient manufacturing processes at small to large scales, providing high-quality cGMP manufacturing to clients around the world. ?? Don’t miss the chance to connect with their team in London this March and learn more about their industry-leading peptide services. ?? Join us: https://hubs.la/Q034TdKn0 #NGB2025 #PeptideManufacturing #API
-
-
This year, Biologics UK becomes NextGen Biomed by Oxford Global! Meet with us and discover how AmbioPharm can help with the manufacturing and development of your clinical and commercial peptide API. https://lnkd.in/du5ZdwvZ ?? Contact us to schedule a meeting in advance. ?? AmbioPharm has additional industry events where we will be available to showcase our peptide manufacturing and development services.? ? ?? Meet with us at an upcoming Conference: TIDES Asia | Feb 26-28 | Kyoto, Japan NextGen Biomed (Biologics UK) | March 12-14 |Booth 28 | London, UK DCAT Week | March 17-20 | NYC, NY USA #NextGenBiomed2025 #NGB2025
-
-
Happy Lunar New Year (新年快乐) from all of us at AmbioPharm! The Lunar New Year is marked by the first new moon of the lunar calendar and has been celebrated for over 3,500 years. According to the Chinese Zodiac, this is the year of the snake. May this year bring you opportunity, potential, and renewal. #LunarNewYear #ChineseNewYear #yearofthesnake
-